Atlas Trials

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Clinical trial NCT00014560 · TERMINATED

Trial details

NCT number
NCT00014560
Sponsor
Dartmouth-Hitchcock Medical Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaLymphoma
Start date
2000-09-28
Primary completion
2003-02-14
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.